S
SD Biotechnologies Co Ltd
KOSDAQ:217480
SD Biotechnologies Co Ltd
KOSDAQ:217480
Price:
499
KRW
35.97%
Market Closed
Market Cap:
₩54.8B
Balance Sheet
Balance Sheet Decomposition
SD Biotechnologies Co Ltd
SD Biotechnologies Co Ltd
Balance Sheet Decomposition is not available for
SD Biotechnologies Co Ltd
SD Biotechnologies Co Ltd
Balance Sheet
SD Biotechnologies Co Ltd
SD Biotechnologies Co Ltd
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
2
|
1 640
|
10 198
|
14 455
|
8 710
|
10 019
|
10 119
|
12 642
|
15 121
|
8 007
|
20 193
|
3 462
|
|
| Cash Equivalents |
2
|
1 640
|
10 198
|
14 455
|
8 710
|
10 019
|
10 119
|
12 642
|
15 121
|
8 007
|
20 193
|
3 462
|
|
| Short-Term Investments |
0
|
0
|
9 550
|
11 600
|
16 960
|
5 778
|
5 056
|
9 983
|
1 130
|
7 534
|
6 817
|
16 104
|
|
| Total Receivables |
305
|
1 371
|
4 300
|
8 727
|
19 569
|
28 200
|
21 122
|
17 799
|
16 748
|
6 123
|
2 953
|
2 137
|
|
| Accounts Receivables |
305
|
1 274
|
4 100
|
7 852
|
16 956
|
17 945
|
12 957
|
12 156
|
10 428
|
6 082
|
2 889
|
2 087
|
|
| Other Receivables |
0
|
97
|
200
|
875
|
2 613
|
10 255
|
8 165
|
5 643
|
6 320
|
41
|
63
|
50
|
|
| Inventory |
629
|
1 234
|
3 790
|
11 792
|
24 052
|
50 238
|
32 989
|
39 589
|
25 336
|
16 700
|
6 898
|
4 817
|
|
| Other Current Assets |
12
|
384
|
627
|
729
|
8 871
|
4 850
|
8 052
|
6 215
|
22 080
|
11 179
|
22 276
|
19 168
|
|
| Total Current Assets |
948
|
4 628
|
28 464
|
47 303
|
78 162
|
99 086
|
77 338
|
86 229
|
80 415
|
44 051
|
59 137
|
45 688
|
|
| PP&E Net |
11
|
238
|
12 371
|
17 709
|
37 334
|
41 735
|
51 445
|
52 927
|
59 260
|
48 284
|
15 904
|
14 624
|
|
| PP&E Gross |
0
|
238
|
12 371
|
17 709
|
37 334
|
41 735
|
51 445
|
52 927
|
59 260
|
48 284
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
26
|
228
|
742
|
3 519
|
5 080
|
4 259
|
6 699
|
9 930
|
25 259
|
0
|
0
|
|
| Intangible Assets |
10
|
8
|
224
|
467
|
2 785
|
2 939
|
1 338
|
1 304
|
1 281
|
465
|
210
|
158
|
|
| Goodwill |
0
|
0
|
0
|
0
|
3 143
|
3 142
|
1 718
|
48
|
48
|
48
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
108
|
38
|
6
|
0
|
0
|
|
| Long-Term Investments |
30
|
3
|
300
|
0
|
3 200
|
1 895
|
5 397
|
4 801
|
4 279
|
3 638
|
864
|
217
|
|
| Other Long-Term Assets |
1
|
87
|
800
|
3 114
|
3 448
|
4 657
|
0
|
846
|
1 144
|
3
|
8
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
3 143
|
3 142
|
1 718
|
48
|
48
|
48
|
0
|
0
|
|
| Total Assets |
1 000
N/A
|
4 965
+397%
|
42 160
+749%
|
68 592
+63%
|
128 073
+87%
|
153 453
+20%
|
137 235
-11%
|
146 262
+7%
|
146 467
+0%
|
96 439
-34%
|
76 123
-21%
|
60 688
-20%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
224
|
1 158
|
1 165
|
4 814
|
6 198
|
4 229
|
3 736
|
6 093
|
5 666
|
8 449
|
1 718
|
2 402
|
|
| Accrued Liabilities |
0
|
236
|
184
|
643
|
1 338
|
1 136
|
1 143
|
1 464
|
1 411
|
786
|
597
|
135
|
|
| Short-Term Debt |
594
|
400
|
0
|
0
|
1 816
|
16 448
|
14 279
|
10 835
|
18 981
|
17 899
|
2 507
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
733
|
733
|
1 192
|
2 021
|
3 445
|
18 174
|
38 314
|
27 853
|
22 930
|
25 030
|
|
| Other Current Liabilities |
359
|
734
|
8 132
|
6 871
|
8 728
|
5 602
|
10 446
|
16 737
|
20 358
|
22 853
|
3 167
|
3 200
|
|
| Total Current Liabilities |
1 177
|
2 529
|
10 214
|
13 060
|
19 272
|
29 435
|
33 049
|
53 303
|
84 730
|
77 840
|
30 919
|
30 766
|
|
| Long-Term Debt |
0
|
0
|
1 467
|
733
|
1 897
|
6 277
|
7 557
|
5 934
|
12 761
|
13 412
|
94
|
124
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
422
|
707
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
1 097
|
1 284
|
4 834
|
5 507
|
4 655
|
3 018
|
1 732
|
1 104
|
686
|
|
| Other Liabilities |
36
|
65
|
70
|
307
|
491
|
646
|
419
|
419
|
0
|
360
|
0
|
0
|
|
| Total Liabilities |
1 213
N/A
|
2 593
+114%
|
11 751
+353%
|
15 198
+29%
|
23 366
+54%
|
41 900
+79%
|
46 532
+11%
|
64 311
+38%
|
100 510
+56%
|
93 343
-7%
|
32 117
-66%
|
31 576
-2%
|
|
| Equity | |||||||||||||
| Common Stock |
400
|
400
|
2 358
|
9 432
|
11 032
|
11 208
|
11 208
|
11 208
|
11 208
|
20 884
|
54 867
|
54 867
|
|
| Retained Earnings |
611
|
1 972
|
20 099
|
42 559
|
56 701
|
62 661
|
41 823
|
33 155
|
10 531
|
83 103
|
90 491
|
105 085
|
|
| Additional Paid In Capital |
0
|
0
|
7 949
|
1 413
|
37 256
|
39 709
|
39 709
|
39 813
|
46 521
|
71 886
|
81 950
|
81 950
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
300
|
465
|
420
|
300
|
3 941
|
0
|
0
|
|
| Other Equity |
2
|
1
|
2
|
9
|
282
|
1 725
|
1 572
|
1 805
|
941
|
6 314
|
2 321
|
2 620
|
|
| Total Equity |
213
N/A
|
2 371
N/A
|
30 409
+1 183%
|
53 395
+76%
|
104 707
+96%
|
111 553
+7%
|
90 704
-19%
|
81 951
-10%
|
45 957
-44%
|
3 096
-93%
|
44 005
+1 321%
|
29 111
-34%
|
|
| Total Liabilities & Equity |
1 000
N/A
|
4 965
+397%
|
42 160
+749%
|
68 592
+63%
|
128 073
+87%
|
153 453
+20%
|
137 235
-11%
|
146 262
+7%
|
146 467
+0%
|
96 439
-34%
|
76 123
-21%
|
60 688
-20%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
16
|
16
|
19
|
19
|
22
|
22
|
22
|
22
|
18
|
29
|
110
|
110
|
|
Switch to:
Switch to:
See Also
Discover More
